← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #945 OF 1,000 MOST-CITED

Written procedures - establish; personnel

FDA cited this observation 15 times across 15 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods15
BY FISCAL YEAR
FY20266
FY20259

How FDA worded it — real examples

You did not establish written procedures for preventing microbial contamination from sick or infected personnel, hygienic practices and determining personnel qualification requirements.

Professional Business Associates Inc · Van Nuys, California · Foods · 2026-06-11

You did not establish written procedures for preventing microbial contamination from sick or infected personnel, hygienic practices and determining personnel qualification requirements.

G&G Supplements · Hialeah, Florida · Foods · 2026-06-03

You did not establish written procedures for determining personnel qualification requirements.

Price Pharmaceuticals, LLC d.b.a. Just Move Supplements · Brookshire, Texas · Foods · 2026-05-18

You did not establish written procedures for preventing microbial contamination from sick or infected personnel and hygienic practices.

VitaWest Nutraceuticals Inc · La Verne, California · Foods · 2026-03-26

You did not establish written procedures for preventing microbial contamination from sick or infected personnel, hygienic practices and determining personnel qualification requirements.

Focus Nutrition · Orem, Utah · Foods · 2026-01-15

You did not establish written procedures for preventing microbial contamination from sick or infected personnel, hygienic practices and determining personnel qualification requirements.

Marine Minerals, Inc. · Mesa, Arizona · Foods · 2025-10-22

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →